Published in Neuropsychopharmacology on April 26, 2017
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Insensitivity to future consequences following damage to human prefrontal cortex. Cognition (1994) 14.92
Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev (1992) 14.45
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl (1970) 10.05
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology (1998) 8.73
Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen (1999) 8.30
A rating scale for drug-induced akathisia. Br J Psychiatry (1989) 7.30
Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl (2002) 7.26
Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict (1988) 6.20
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry (1985) 6.16
Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry (2005) 4.85
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction (2006) 4.79
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
Dose-related neurocognitive effects of marijuana use. Neurology (2002) 3.25
Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl (1993) 3.24
The time course and significance of cannabis withdrawal. J Abnorm Psychol (2003) 2.70
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry (2015) 2.44
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry (2005) 2.14
Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc (2007) 2.05
Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry (2011) 2.04
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry (2011) 2.03
Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol (2005) 1.96
Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry (2008) 1.89
Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry (1991) 1.88
Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry (2010) 1.81
The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) (2006) 1.72
The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev (2008) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study. BMJ Open (2016) 1.48
Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther (1985) 1.47
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol (2010) 1.31
Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull (2009) 1.30
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.11
Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol (2008) 1.10
Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend (2014) 1.08
The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr Res (2011) 1.08
Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol (1999) 1.07
Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med (1992) 1.05
CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain Cogn (2005) 1.00
The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl) (2009) 0.99
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (2010) 0.98
The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull (2011) 0.97
Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction (2011) 0.95
Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med (2009) 0.92
The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res (2007) 0.90
Does marijuana use cause long-term cognitive deficits? JAMA (2002) 0.90
Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr Res (2010) 0.90
Pretreatment status and its relationship to the length of drying-out period. Psychopharmacol Bull (1976) 0.90
Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biol Psychiatry (2015) 0.90
Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr (1991) 0.89
Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother (2008) 0.89
Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophr Res (2006) 0.88
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat. Pain (2013) 0.88
The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry (2007) 0.87
Short-term and long-term memory in early temporal lobe dysfunction. Neuropsychology (1998) 0.84
[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol (2013) 0.84
The Hopkins Verbal Learning Test and CVLT: a preliminary comparison. Arch Clin Neuropsychol (1998) 0.84
The Pharmacokinetics of the THC in fat and brain: Resulting functional responses to marihuana smoking: G. Nahas, Volume 16 Issue 3, April 2001, pages 247-255. Hum Psychopharmacol (2001) 0.80
Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder. Schizophr Res (2012) 0.80
Prognosis of schizophrenia in persons with and without a history of cannabis use. Psychol Med (2014) 0.79
A survey of neuropsychologists' beliefs and practices with respect to the assessment of effort. Arch Clin Neuropsychol (2007) 0.79
Neurocognitive functions of heavy cannabis using schizophrenia patients. Eur Psychiatry (2011) 0.78
Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Res (2012) 0.78
Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology (Berl) (2015) 0.76
A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophr Res (2017) 0.76
Distress related to subclinical negative symptoms in a non-clinical sample: Role of dysfunctional attitudes. Psychiatry Res (2015) 0.75